Which of the following is a drug that produces vasodilation, improves cardiac output, and lowers blood pressure?

Choice A reason: Tachycardia doesn’t dictate dose increases; orthostasis is the concern. Slow movement prevents falls, per nursing standards. This misaligns universally, distinctly missing antihypertensive safety teaching.

Choice B reason: BP checks every 8 hours aren’t standard; slow positioning addresses hypotension. This overcomplicates, per nursing pharmacology. It’s universally distinct, not routine discharge advice.

Choice C reason: Slow position changes prevent orthostatic hypotension, common with antihypertensives. This ensures safety, per nursing standards. It’s universally recognized, distinctly critical for patient education on these drugs.

Choice D reason: Tyramine relates to MAOIs, not typical antihypertensives. Slow movement fits, per nursing pharmacology. This errors universally, distinctly irrelevant to standard antihypertensive precautions.

Choice A reason: Decreasing BP is correct; other options don’t apply. This choice errors per nursing pharmacology. It’s universally distinct, denies the right answer.

Choice B reason: Vasotec, an ACE inhibitor, lowers BP by vessel relaxation. This aligns with nursing pharmacology standards. It’s universally applied, distinctly effective.

Choice C reason: Elevating BP opposes ACE inhibitor action entirely. Lowering is correct. This errors per nursing standards. It’s universally distinct, reverses function.

Choice D reason: No effect contradicts Vasotec’s BP-lowering purpose. This choice misaligns with nursing pharmacology. It’s universally distinct, errors in drug role.